Webinar via Microsoft Teams Live Event
Please click on this link just before the start of the webinar to join
Kirby Institute Seminar Series presents
Dr Behzad Hajarizadeh
Behzad Hajarizadeh is a clinical epidemiologist, and a Senior Lecturer at the Kirby Institute, UNSW Sydney. He trained as a Medical Practitioner and has an MPH and PhD in Medicine. His research interests include viral hepatitis natural history, and clinical care in prison settings and among people who inject drugs.
Treatment-as-prevention incorporates treatment as a tool for limiting spread of an infection in epidemics in a particular setting. The Surveillance and Treatment of Prisoners with hepatitis C (SToP-C) study is the first study globally, providing empirical data of hepatitis C treatment-as-prevention in the prison setting.